Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss
By
Isabella Ward
Crisped on the outside, thoughtful enough on the inside.
Summary
Life Biosciences has dosed the first human patient with ER-100, a cellular rejuvenation therapy designed to reverse age-related sight loss by restoring damaged optic nerve cells. The drug, previously shown to restore vision in monkeys, is now being tested for safety in approximately 18 adults with glaucoma and NAION over the next year. This marks the first time a cellular rejuvenation therapy claiming to reverse aging in cells has been tested on humans.
Key quotes
· 3 pulledA longevity startup has dosed its first patient with a drug to reverse age-related sight loss.
ER-100 is designed to rejuvenate those cells so that they work again and restore sight.
It is the first ever cellular rejuvenation therapy
You might also wanna read
Method to reverse cellular ageing is about to be tested in humans
Psilocybin Delays Cellular Aging and Extends Lifespan in Preclinical Study
Psilocybin, the active compound in psychedelic mushrooms, significantly delayed cellular aging and extended lifespan in a preclinical study
neurosciencenews.com·11mo ago
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
The diabetes drug Ozempic has shown significant anti-aging effects in a clinical trial, reversing biological age by an average of 3.1 years
trial.medpath.com·10mo ago
OpenAI and Retro Biosciences Develop AI Model That Achieves 50x Improvement in Stem Cell Reprogramming
OpenAI collaborated with Retro Biosciences to develop GPT-4b micro, a specialized AI model for protein engineering. The AI-designed proteins
openai.com·9mo ago
Stanford Medicine Study Uncovers Biomolecular Shifts in 40s and 60s
A Stanford Medicine study reveals significant biomolecular changes in individuals in their 40s and 60s, impacting molecules and microorganis
med.stanford.edu·11mo ago